Comparison of a quantitative PCR method with FISH for the assessment of the four aneuploidies commonly evaluated in CLL patients

被引:18
作者
Bastard, C.
Raux, G.
Fruchart, C.
Parmentier, F.
Vaur, D.
Penther, D.
Troussard, X.
Nagib, D.
Lepretre, S.
Tosi, M.
Frebourg, T.
Tilly, H.
机构
[1] Ctr Henri Becquerel, Lab Genet Oncol, Grp Etud Proliferat Lymphoides, F-76000 Rouen, France
[2] INSERM, U614, IFR23, Rouen, France
[3] Ctr Francois Baclesse, Dept Hematol, F-14021 Caen, France
[4] CHU Caen, Hematol Lab, F-14000 Caen, France
关键词
CLL; prognosis; imbalance; FISH; quantitative PCR;
D O I
10.1038/sj.leu.2404727
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Four chromosomal defects associated with outcome are commonly evaluated by fluorescent in situ hybridization (FISH) in chronic lymphocytic leukemia (CLL), namely deletions of the 13q13-q14, 11q22 and 17p13 regions and trisomy 12. In this study, we compared a quantitative PCR method - quantitative multiplex PCR of short fluorescent fragment (QMPSF) - with FISH for the detection of these acquired aneuploidies in a series of 110 patients with Binet stage A CLL. Genes located in the deleted or gained regions were selected as target genes and amplified using a method based on the simultaneous amplification of short fluorescent genomic fragments under quantitative conditions. A chromosomal imbalance involving one or several of the four loci was detected by either method in 72 patients (65%). A chromosome 13 deletion was present in 61 patients (54%), a 11q22 deletion in nine (8%), a trisomy 12 in nine and a 17p deletion in one. FISH and QMPSF results were identical for 103 out of 110 patients and discrepancies could be explained in most cases. This study demonstrates that a quantitative multiplex PCR represents a cost-effective method that could replace FISH in CLL patients. However, although QMPSF is perfectly adapted to the detection of primary defects, care should be taken when searching for clonal evolutions present in a small proportion of tumor cells.
引用
收藏
页码:1460 / 1463
页数:4
相关论文
共 23 条
  • [1] BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO
  • [2] 2-V
  • [3] Rapid detection of noval BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments
    Casilli, F
    Di Rocco, ZC
    Gad, S
    Tournier, I
    Stoppa-Lyonnet, D
    Frebourg, T
    Tosi, M
    [J]. HUMAN MUTATION, 2002, 20 (03) : 218 - 226
  • [4] CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia
    Chevallier, P
    Penther, D
    Avet-Loiseau, H
    Robillard, N
    Ifrah, N
    Mahé, B
    Hamidou, M
    Maisonneuve, H
    Moreau, P
    Jardel, H
    Harousseau, JL
    Bataille, R
    Garand, R
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (01) : 142 - 150
  • [5] ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia
    Crespo, M
    Bosch, F
    Villamor, N
    Bellosillo, B
    Colomer, D
    Rozman, M
    Marcé, S
    López-Guillermo, A
    Campo, E
    Montserrat, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18) : 1764 - 1775
  • [6] Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients:: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression
    Dicker, Frank
    Schnittger, Susanne
    Haferlach, Torsten
    Kern, Wolfgang
    Schoch, Claudia
    [J]. BLOOD, 2006, 108 (09) : 3152 - 3160
  • [7] Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner, H
    Stilgenbauer, S
    Benner, A
    Leupolt, E
    Kröber, A
    Bullinger, L
    Döhner, K
    Bentz, M
    Lichter, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) : 1910 - 1916
  • [8] P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO THERAPY WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS
    DOHNER, H
    FISCHER, K
    BENTZ, M
    HANSEN, K
    BENNER, A
    CABOT, G
    DIEHL, D
    SCHLENK, R
    COY, J
    STILGENBAUER, S
    VOLKMANN, M
    GALLE, PR
    POUSTKA, A
    HUNSTEIN, W
    LICHTER, P
    [J]. BLOOD, 1995, 85 (06) : 1580 - 1589
  • [9] 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis
    Dohner, H
    Stilgenbauer, S
    James, MR
    Benner, A
    Weilguni, T
    Bentz, M
    Fischer, K
    Hunstein, W
    Lichter, P
    [J]. BLOOD, 1997, 89 (07) : 2516 - 2522
  • [10] Immunoglobulin V genes and CD38 expression in CLL
    Hamblin, BJ
    Orchard, JA
    Gardiner, A
    Oscier, DG
    Davis, Z
    Stevenson, FK
    [J]. BLOOD, 2000, 95 (07) : 2455 - 2456